The Helping End Addiction Long-Term (HEAL) New Innovator Award supports a postdoctoral or newly independent Early Stage Investigator of exceptional creativity who proposes novel, original and insightful research concepts with the potential to produce a major impact, test scientific paradigms, or advance key concepts on broad, important problems in biomedical research related to pain, opioid use disorder (OUD), and/or overdose (OD).
Donor Name: National Institutes of Health (NIH)
State: All States
County: All Counties
Type of Grant: Award
Deadline (mm/dd/yyyy): 05/22/2022
Grant Size: $1,500,000
Grant Duration: 3 years
Details:
This funding opportunity announcement (FOA) aims to support scientists with high-impact, outside the box ideas. Novel treatments for pain, opioid addiction, and overdose are crucial to addressing the ongoing opioid crisis. The development of new treatment strategies is made difficult by the extraordinary complexity of both pain and addiction, consisting of physical, emotional, and social components. As such, effective treatment will require highly innovative ideas. These transformative, boundary-pushing applications are often risky or at a stage too early to fare well in the traditional peer review process. This is particularity true for applications from early-stage investigators without the benefit of an extensive track-record to which to point. In order to foster fresh and original ideas from young investigators in the HEAL fields, the participating NIH Institutes and Centers propse a HEAL-specific New Innovator Award (DP2).
The NIH Director’s New Innovator Award addresses two important goals: stimulating highly innovative research and supporting promising Early-Stage Investigators. Early-Stage Investigators may have exceptionally innovative research ideas, but not the preliminary data required to fare well in the traditional NIH peer review system. As part of NIH’s commitment to increasing opportunities for Early-Stage Investigators, it has created the NIH Director’s New Innovator Award to support outstandingly creative Early-Stage Investigators who propose highly innovative research projects with the potential for unusually high impact.
Funding Information
- The combined budget for direct costs for the three-year project period may not exceed $1,500,000. No more than $500,000 may be requested in any single year.
- The total project period may not exceed three years.
Eligibility Criteria
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- State governments
- Special district governments
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Small businesses
- Independent school districts
- Private institutions of higher education
- Public and State controlled institutions of higher education
- County governments
- Public housing authorities/Indian housing authorities
- City or township governments
- For profit organizations other than Small businesses
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
For more information, visit Grants.gov.
